4//SEC Filing
Schimmelpennink Evert B. 4
Accession 0001815776-25-000003
CIK 0001815776other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:20 PM ET
Size
434.0 KB
Accession
0001815776-25-000003
Insider Transaction Report
Form 4
Schimmelpennink Evert B.
DirectorPresident, CEO and Secretary
Transactions
- Award
Stock Option (right to buy)
2025-01-09+279,100→ 279,100 totalExercise: $26.34Exp: 2035-01-08→ Common Stock (279,100 underlying)
Footnotes (1)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean January 9, 2025.
Issuer
LENZ Therapeutics, Inc.
CIK 0001815776
Entity typeother
Related Parties
1- filerCIK 0001713795
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:20 PM ET
- Size
- 434.0 KB